Your browser doesn't support javascript.
loading
The EGALITY study: a confirmatory, randomized, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate-to-severe chronic plaque-type psoriasis.
Griffiths, C E M; Thaçi, D; Gerdes, S; Arenberger, P; Pulka, G; Kingo, K; Weglowska, J; Hattebuhr, N; Poetzl, J; Woehling, H; Wuerth, G; Afonso, M.
Afiliação
  • Griffiths CEM; Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, U.K.
  • Thaçi D; Comprehensive Center for Inflammation Medicine, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
  • Gerdes S; Psoriasis-Center at the Department of Dermatology, Universitaetsklinikum, Schleswig-Holstein, Campus Kiel, Arnold-Heller-Straße 3, Haus 19, 24105, Kiel, Germany.
  • Arenberger P; Department of Dermatology, Charles University Third Medical Faculty and Faculty Hospital Kralovske Vinohrady, Srobarova 50, Prague 10, 10034, Czech Republic.
  • Pulka G; Grazyna Pulka Specjalistyczny Osrodek 'ALL-MED' ul. Sw. Marka 31/IU, ul. Sw. Krzyza 16/14, Krakow, 31-023, Poland.
  • Kingo K; Dermatology Clinic, Tartu University Hospital, Raja 31, Tartu, 50417, Estonia.
  • Weglowska J; Department of Dermatology, Wojewodzki Szpital Specjalistyczny we Wroclawiu, ul. Kamienskiego 73a, Wroclaw, 51-124, Poland.
  • Hattebuhr N; Global Clinical Development, Biopharmaceuticals, Hexal AG, Industriestraße 25, D 83607, Holzkirchen, Germany.
  • Poetzl J; Global Clinical Development, Biopharmaceuticals, Hexal AG, Industriestraße 25, D 83607, Holzkirchen, Germany.
  • Woehling H; Global Clinical Development, Biopharmaceuticals, Hexal AG, Industriestraße 25, D 83607, Holzkirchen, Germany.
  • Wuerth G; Global Clinical Development, Biopharmaceuticals, Hexal AG, Industriestraße 25, D 83607, Holzkirchen, Germany.
  • Afonso M; Global Clinical Development, Biopharmaceuticals, Hexal AG, Industriestraße 25, D 83607, Holzkirchen, Germany.
Br J Dermatol ; 176(4): 928-938, 2017 Apr.
Article em En | MEDLINE | ID: mdl-27787890
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Medicamentos Biossimilares / Etanercepte Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Medicamentos Biossimilares / Etanercepte Idioma: En Ano de publicação: 2017 Tipo de documento: Article